SHC Government Contracts & Federal Awards (2026)

Executive ownership filings: SHC fundamental summary

Corporate leadership at Sotera Health Co (SHC) reported 10 open-market transactions on SEC Form 4 across the trailing twelve-month window through 2026-03-06. Every recorded transaction represented an open-market disposition, yielding 10 sales totaling $1.80B. These transactions provide verifiable ownership telemetry for asset managers evaluating corporate governance across Services-Misc Health & Allied Services, NEC companies. Securities compliance statutes require corporate officers to publish transactional filings promptly, anchoring public market analysis in official regulatory disclosures. Institutional market participants evaluate corporate governance disclosures alongside primary market fundamentals to gauge leadership alignment.

SHC insider buying and selling over the past year

Insiders at Sotera Health Co only sold stock in the open market over the past year: 10 Form 4 sales totaling $1.80B, against no open-market purchases.

None of the 10 sales were flagged as Rule 10b5-1 plan trades, meaning each one was a discretionary decision at the time of filing. Activity clustered in 2025-12 (4 trades) and 2025-11 (3 trades); the latest filing in this window is dated 2026-03-06. Trading records delineate 10 opportunistic executions versus 0 routine administrative transactions. Cumulative open-market transactions involved 114,670,000 shares, representing 40.2% of the 285,374,795 total shares outstanding. The single largest trade was a sale of 18,000,000 shares worth $281.70M on 2025-11-10.

SHC insider cost basis and market valuation scenarios

Benchmarking management execution levels against market close indicators helps investors determine the strategic conviction embedded in open-market insider volumes. Liquidity parameters across secondary venues ensure that corporate ownership distributions for Sotera Health Co clear orderly alongside routine institutional market turnover.

Congressional trading disclosures for SHC

Official financial filings mandated by the STOCK Act of 2012 contain zero recorded purchases or sales of Sotera Health Co (SHC) by federal lawmakers across monitored congressional sessions. Neither Senate nor House representatives reported personal ownership transactions in the equity.

Sotera Health Co federal procurement profile

Contract registries indicate zero direct procurement obligations assigned to Sotera Health Co, confirming an operational focus centered on commercial client transactions without government award dependence.

Sources and method

Analytics displayed across this company dossier originate from primary SEC EDGAR archives in Gemral Edge. Tabulations evaluate open-market transactions strictly, omitting derivative grants and tax-related share withholdings.

• SEC EDGAR Form 4 (edge_insider_trades, codes P/S open-market only) — as of 2026-03-06

SHC data questions

Are SHC insiders buying or selling stock?

Insiders at Sotera Health Co only sold stock in the open market over the past year: 10 Form 4 sales totaling $1.80B, against no open-market purchases.

Has any member of Congress traded SHC stock?

No. Congressional records under the STOCK Act of 2012 show zero disclosed trades for SHC over the monitored period.